Head-To-Head Review: Precipio (NASDAQ:PRPO) vs. Zhongchao (NASDAQ:ZCMD)

Zhongchao (NASDAQ:ZCMD) and Precipio (NASDAQ:PRPO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, risk, dividends and analyst recommendations.

Earnings and Valuation

This table compares Zhongchao and Precipio”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zhongchao	$15.86 million	0.32	-$640,000.00	N/A	N/A
Precipio	$18.53 million	2.51	-$4.29 million	($0.82)	-32.35

Zhongchao has higher earnings, but lower revenue than Precipio.

Analyst Recommendations

This is a summary of current recommendations for Zhongchao and Precipio, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zhongchao	1	0	0	0	1.00
Precipio	1	0	0	0	1.00

Insider & Institutional Ownership

1.7% of Zhongchao shares are owned by institutional investors. Comparatively, 10.5% of Precipio shares are owned by institutional investors. 28.6% of Zhongchao shares are owned by company insiders. Comparatively, 16.9% of Precipio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Zhongchao and Precipio’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Zhongchao	N/A	N/A	N/A
Precipio	-5.50%	-10.07%	-6.71%

Summary

Zhongchao beats Precipio on 5 of the 8 factors compared between the two stocks.

About Zhongchao

Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.

About Precipio

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.